ADIPOQ and metabolic dysfunction-associated steatotic liver disease: As adiponectin is known as a protective molecule in the development of NAFLD [48], [49], the lower adiponectin concentrations [50], [51] associated with vitamin D deficiency in subjects with diabetes or insulin resistance may be responsible for the development of NAFLD in those with high metabolic risk.